Navigation Links
Escalon(R) Enhances Position Within IVD Reagent Market with Strategic Acquisition of JAS Diagnostics
Date:6/5/2008

WAYNE, Pa., June 5 /PRNewswire-FirstCall/ -- Escalon Medical Corp. (Nasdaq Capital Market: ESMC) announced today that on May 30, 2008 its wholly owned subsidiary, Drew Scientific, Inc. ("Drew") acquired JAS Diagnostics, Inc. ("JAS"). JAS is a privately-held manufacturer of class I and II in vitro diagnostics ("IVD") reagents that markets its products to physician, reference, hospital and veterinary laboratories throughout the world. JAS, based in Miami, Florida, generates annual revenues of approximately $2.0 million. Drew purchased 100% of the outstanding shares of JAS for approximately $1,200,000 in cash and $800,000 in notes payable.

"Consistent with our strategic objective to expand our presence in the reagent segment of the IVD market, we are pleased to announce the acquisition of JAS, a value-creating bolt-on acquisition that adds intangible assets to the Drew existing product line," said Richard J. DePiano Sr., Chairman and Chief Executive Officer. "JAS' strong customer relationships, well-respected product portfolio, and research and development competencies will be an excellent complement to our Drew business. While Drew is focused on the equipment side of the IVD business, JAS synergistically expands our current position into the clinical chemistry consumable market. We look forward to the JAS team becoming part of our organization and contributing to our future growth."

JAS was established in 2000 and specializes in the manufacture of a broad range of liquid stable, diagnostics chemistry reagents used in IVD tests. Many of these reagents are single vial stable, which offer ease of use, increased speed of results, and extended on-board stability, among other superior performance characteristics. JAS has CE marks for marketing for its products in Europe, along with ISO 9001 certification. JAS offers over 150 products and has obtained FDA 510(k) marketing clearance and CLIA classification for its manufactured products as required. Notabl
'/>"/>

SOURCE Escalon Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Escalon(R) Reports Financial Results for 2007 Fiscal Year
2. Escalon(R) Reports First Quarter Fiscal 2008 Results
3. Escalon(R) Announces FDA 510(K) Clearance for D3 Hematology System
4. Escalon(R) Announces Executive Promotions
5. Escalon(R) Announces China Registration for Sonomed PacScan(R) and E/Z-Scan(R) Series of A-scan, Pachymeter and B-Scan Systems
6. Creative Technology Services Enhances its Global Competitiveness with Additional Regulatory Certifications
7. American Heart Association Enhances eLearning for Emergency Cardiovascular Care (ECC)
8. Study finds limiting work hours for surgical residents enhances training
9. McGraw-Hill Professional Enhances Library Access to Medical and Engineering Resources
10. Sterling Life Enhances Marketing Operations Controls to Better Serve Medicare Beneficiaries
11. Creatine in addition to exercise enhances strength in older adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 2015 In April, the Science Museum ... raise autism awareness by illuminating Richmond’s historic train station ... one of thousands of businesses, schools and organizations who ... lighting to brighten up the night sky – and ... collaborative effort is the 8th annual awareness campaign spearheaded ...
(Date:4/1/2015)... 2015 Levi's® Stadium , located in ... United States. The San Francisco 49ers from the National Football ... last year, Levi’s Stadium has been the home of countless ... held here thus far include a game from the 2015 ... and San Jose Sharks, Wrestlemania 31 and an International Friendly ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 This year for ... the Oral Cancer Foundation for an Open House to offer ... 9 a.m. to 4 p.m. An appointment is required and ... dental office at 212-689-0024. In addition, Herald Square Dental ... during the entire month of April at the reduced cost ...
(Date:4/1/2015)... April 01, 2015 NTOCC today launches ... of care tools that seek to improve care transitions ... program, NTOCC hopes to bring light to tools or ... of care across the healthcare industry through the promotion ... advance collaborative patient-care. Following that vision, the Knowledge & ...
(Date:4/1/2015)... The panel session will look at the ... build a program that can grow in a privacy-friendly ... down the line. This topic has taken on even ... OBD-II port dongles aren’t as secure as the automobile ... reported that Progressive’s Snapshot dongles contained very significant security ...
Breaking Medicine News(10 mins):Health News:Levi's® Stadium Tickets for Super Bowl 50, Kenny Chesney & Jason Aldean, One Direction, Taylor Swift and Luke Bryan Available at Discounted Prices at TicketDown.com 2Health News:Levi's® Stadium Tickets for Super Bowl 50, Kenny Chesney & Jason Aldean, One Direction, Taylor Swift and Luke Bryan Available at Discounted Prices at TicketDown.com 3Health News:Herald Square Dental Celebrates Oral Cancer Awareness Month 2Health News:National Transitions of Care Coalition Launches Knowledge & Resource Center 2Health News:National Transitions of Care Coalition Launches Knowledge & Resource Center 3Health News:TU-Automotive: Office of The Privacy Commissioner of Canada To Set Out Privacy Considerations Surrounding UBI Products 2Health News:TU-Automotive: Office of The Privacy Commissioner of Canada To Set Out Privacy Considerations Surrounding UBI Products 3
... LAKE CITYFindings of a clinical trial reported at SNM,s ... agent could improve diagnosis of recurrent prostate cancer and ... "Despite definitive treatment, about 30 percent ... of the division of nuclear medicine and molecular imaging ...
... Public Health (HSPH) have found that children and adolescents ... smoke-free public places have significantly lower levels of a ... in counties with no smoke-free laws. The children ... laws had 39% lower prevalence of cotinine in their ...
... results from a major clinical trial show that ... women with advanced ovarian cancer and then continuing ... extends progression-free survival. Women receiving the new treatment ... 14.1 months, compared to 10.3 months for women ...
... June 5 The combination of two different chemotherapies ... cancers is not effective against advanced melanoma, according to ... 46th annual meeting of the American Society of Clinical ... we learn something important about the treatment of melanoma," ...
... and Tasigna than Gleevec , SATURDAY, June 5 (HealthDay ... (Tasigna), appear better than imatinib (Gleevec) in treating patients ... considered as first-line treatments, two new studies show. , ... be presented Saturday at the American Society of Clinical ...
... -- Two drugs approved for treatment of drug-resistant chronic ... a first therapy than the existing front-line medication, according ... England Journal of Medicine . Separate international ... year of treatment between the standard-of-care drug imatinib, also ...
Cached Medicine News:Health News:Molecular imaging detects recurrent prostate cancer 2Health News:Smoke-free air laws effective at protecting children from secondhand smoke 2Health News:New treatment regimen shown effective against advanced ovarian cancer 2Health News:Combination treatment regimen not effective against advanced melanoma 2Health News:Newer Drugs Beat Gleevec in Head-to-Head Trials 2Health News:Newer Drugs Beat Gleevec in Head-to-Head Trials 3Health News:Newer Drugs Beat Gleevec in Head-to-Head Trials 4Health News:Second-line CML drugs evoke faster, better front-line remissions 2Health News:Second-line CML drugs evoke faster, better front-line remissions 3
(Date:4/1/2015)... April 1, 2015  Egalet Corporation (Nasdaq: ... company focused on developing, manufacturing and marketing innovative ... offering of $60.0 million aggregate principal amount of ... in a private placement to qualified institutional buyers ... of 1933, as amended (the "Act"). Egalet also ...
(Date:4/1/2015)... -- Boston Scientific Corporation (NYSE: BSX ) will webcast a ... ET to review financial results and business highlights for the ... announcing first quarter financial results prior to the conference call. ... Mahoney , president and chief executive officer, and Dan ... A live webcast of the conference call will be ...
(Date:4/1/2015)... GLEN BURNIE, Md. , April 1, 2015 ... in patient recruitment solutions for the clinical research ... to help with a dermatology study that was ... its expert recruitment strategies and customized site support ... was screening and enrolling, and also increased the ...
Breaking Medicine Technology:Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 2Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 3Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 4Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 5Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 6Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 7Boston Scientific To Webcast Conference Call On First Quarter 2015 Financial Results 2CSSi Quadruples Screening Activity and Speeds Enrollment for Pediatric Dermatology Study 2
... ACCESS PHARMACEUTICALS, INC. ... a biopharmaceutical company leveraging its proprietary drug-delivery platforms to ... and diabetes, reported it has been receiving ... MuGard for patients undergoing radiation and chemotherapy for various ...
... Inc. (Nasdaq: CHBT ) ("China-Biotics" or "the Company"), ... today reported its unaudited financial results for the third quarter and ... Third Quarter FY2011 ... y-o-y to $32.4 million; Bulk products sales increased ...
Cached Medicine Technology:Access Pharmaceuticals Receives Early MuGard Prescriber Anecdotal Feedback Validating Larger Target Market Potential 2Access Pharmaceuticals Receives Early MuGard Prescriber Anecdotal Feedback Validating Larger Target Market Potential 3Access Pharmaceuticals Receives Early MuGard Prescriber Anecdotal Feedback Validating Larger Target Market Potential 4China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 2China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 3China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 4China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 5China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 6China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 7China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 8China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 9China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 10China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 11
... knee during surgery. Slotted base allows the ... knee surgery. Slots are also designed to allow ... can be sterilized by either gas or steam ... can be clamped over the sterile drape to ...
... Rod System offers the surgeon a simple ... rodding and plating. The rods are flexible, ... and enhanced healing4 The fluted non-reamed design ... into the canal. By requiring only one ...
Interphlex Flexible Stablization Rods offer correction of Hammer Toes with a High level of Flexibility while maintaining correct toe length and shape....
The True/Fix Compression Hip Screw System offers a wide variety of plate and screw sizes available....
Medicine Products: